1. Scrip
  2. >>Focus On Asia

China VBP, Localization And Other Strategies - How Far And Which Way?

EY Partner On China Developments

 
• By Brian Yang

Could health sector players encounter issues similar to those facing Tesla in China, a country which virtually saved the electric vehicle maker but where it is now facing challenges? Are there any lessons to be learned from a success story under China's volume-based procurement scheme? A partner at EY looks at these and other issues in an interview with Scrip.

Red and blue arrows up and down with dollar coins, mixed fortunes
VBP roll-out forces health players to consider new localization options in China • Source: Shutterstock

In an exclusive interview, Hua Su, Life Science and Healthcare practice leader and partner at Ernest &Young (EY) Parthenon, shares his recent comprehensive research on China's volume-based procurement (VBP) scheme for pharma and medtech products, as well as options for companies hit by spreading price-cutting schemes and pondering their next strategic moves in this key market.

Read the full article – start your free trial today!

Join thousands of industry professionals who rely on Scrip for daily insights

  • Start your 7-day free trial
  • Explore trusted news, analysis, and insights
  • Access comprehensive global coverage
  • Enjoy instant access – no credit card required
Start Free Trial

Already a subscriber?

More from China

More from Focus On Asia